DK1583525T3 - Anvendelse af porphyrinsyntesesubstanser i kombination med salicylater og antioxdanter til anvendelse i fototerapi til behandling af hud- og/eller ledsygdomme - Google Patents
Anvendelse af porphyrinsyntesesubstanser i kombination med salicylater og antioxdanter til anvendelse i fototerapi til behandling af hud- og/eller ledsygdommeInfo
- Publication number
- DK1583525T3 DK1583525T3 DK03815354.0T DK03815354T DK1583525T3 DK 1583525 T3 DK1583525 T3 DK 1583525T3 DK 03815354 T DK03815354 T DK 03815354T DK 1583525 T3 DK1583525 T3 DK 1583525T3
- Authority
- DK
- Denmark
- Prior art keywords
- skin
- phototherapy
- salicylates
- antioxidants
- treatment
- Prior art date
Links
- 208000012659 Joint disease Diseases 0.000 title abstract 2
- 150000004032 porphyrins Chemical class 0.000 title abstract 2
- 239000003963 antioxidant agent Substances 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000001126 phototherapy Methods 0.000 title 1
- 150000003873 salicylate salts Chemical class 0.000 title 1
- 208000017520 skin disease Diseases 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 201000004624 Dermatitis Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 238000002428 photodynamic therapy Methods 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10301917A DE10301917B4 (de) | 2003-01-17 | 2003-01-17 | Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren |
| PCT/DE2003/004254 WO2004064827A1 (de) | 2003-01-17 | 2003-12-23 | Verwendung von substanzen der porphyrinsynthese für die anwendung in der phototherapie sowie zur behandlung von haut- und/oder gelenkerkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1583525T3 true DK1583525T3 (da) | 2011-01-03 |
Family
ID=32602752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03815354.0T DK1583525T3 (da) | 2003-01-17 | 2003-12-23 | Anvendelse af porphyrinsyntesesubstanser i kombination med salicylater og antioxdanter til anvendelse i fototerapi til behandling af hud- og/eller ledsygdomme |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20070099878A1 (enExample) |
| EP (1) | EP1583525B1 (enExample) |
| JP (1) | JP2006514072A (enExample) |
| AT (1) | ATE479431T1 (enExample) |
| AU (1) | AU2003300499A1 (enExample) |
| CY (1) | CY1110957T1 (enExample) |
| DE (2) | DE10301917B4 (enExample) |
| DK (1) | DK1583525T3 (enExample) |
| ES (1) | ES2351971T3 (enExample) |
| PT (1) | PT1583525E (enExample) |
| RU (1) | RU2336078C2 (enExample) |
| SI (1) | SI1583525T1 (enExample) |
| WO (1) | WO2004064827A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005019628A1 (de) * | 2005-04-26 | 2006-11-09 | Technische Universität Braunschweig | Formulierung zur dermalen Anwendung |
| DE102011117364A1 (de) * | 2011-10-29 | 2013-05-02 | Merck Patent Gmbh | Hautaufheller in der Phototherapie |
| DE202013003573U1 (de) | 2013-04-16 | 2013-06-04 | Gerhard Saalmann | Ganzkörper-Belichtungseinheit |
| RU2712806C1 (ru) * | 2019-05-20 | 2020-01-31 | Федеральное государственное бюджетное учреждение "Государственный научный центр лазерной медицины имени О.К. Скобелкина Федерального медико-биологического агентства" | Способ лечения больных перипротезной инфекцией после эндопротезирования сустава |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5145686A (en) * | 1982-02-03 | 1992-09-08 | Efamol Limited | Topical pharmaceutical compositions |
| IL68965A (en) * | 1983-06-13 | 1987-02-27 | Rafa Labor Ltd | Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders |
| US4647453A (en) * | 1984-10-18 | 1987-03-03 | Peritain, Ltd. | Treatment for tissue degenerative inflammatory disease |
| US5368841A (en) * | 1993-02-11 | 1994-11-29 | The General Hospital Corporation | Photodynamic therapy for the destruction of the synovium in the treatment of rheumatoid arthritis and the inflammatory arthritides |
| DE4320871C2 (de) * | 1993-06-24 | 1995-05-04 | Beiersdorf Ag | Kosmetische und dermatologische Zubereitungen mit einem Gehalt an delta-Aminolävulinsäure |
| WO1996006602A1 (en) * | 1993-08-27 | 1996-03-07 | Noven Pharmaceuticals, Inc. | COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID AND PHARMACEUTICAL EQUIVALENTS THEREOF |
| DE4440112A1 (de) * | 1994-11-11 | 1996-05-15 | Jan H Dr Wilkens | Bestrahlungsanordnung zur Behandlung von Hauterkrankungen |
| US5530157A (en) * | 1995-02-16 | 1996-06-25 | Scios Nova Inc. | Anti-inflammatory benzoic acid derivatives |
| KR100444007B1 (ko) * | 1995-03-10 | 2004-12-03 | 포토큐레 에이에스에이 | 광화학치료또는진단에사용하기위한5-아미노레불린산의에스테르 |
| EP0959879B1 (en) * | 1996-10-10 | 2004-05-06 | The General Hospital Corporation | Photodynamic therapy for the treatment of osteoarthritis |
| RU2145247C1 (ru) * | 1998-04-10 | 2000-02-10 | Жаров Владимир Павлович | Фотоматричное терапевтическое устройство для лечения протяженных патологий |
| DE69940738D1 (de) * | 1998-07-09 | 2009-05-28 | Curelight Medical Ltd | Vorrichtung und verfahren zur wirkungsvollen hochenergetischen photodynamischen therapie von akne vulgaris und seborrhoe |
| DE19852245A1 (de) * | 1998-11-12 | 2000-05-18 | Asat Ag Applied Science & Tech | 5-Aminolävulinsäure-Nanoemulsion |
| DE10003620A1 (de) * | 2000-01-28 | 2001-08-02 | Asat Ag Applied Science & Tech | 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln |
| ES2243549T3 (es) * | 2000-09-08 | 2005-12-01 | Vivier Canada Inc. | Soluciones de acido ascorbico estabilizadas. |
| DE10063076A1 (de) | 2000-12-18 | 2002-06-27 | Medac Klinische Spezialpraep | Verwendung von 5-Aminolävulinsäure zur Restenose-Prophylaxe |
| CA2450370A1 (en) * | 2001-06-11 | 2002-12-19 | Jody Mesaros | Accelerators for increasing the rate of formation of free radicals and reactive oxygen species |
| US6723750B2 (en) * | 2002-03-15 | 2004-04-20 | Allergan, Inc. | Photodynamic therapy for pre-melanomas |
| US20040048842A1 (en) * | 2002-09-10 | 2004-03-11 | Mcmillan Kathleen | Method of treating skin disorders |
-
2003
- 2003-01-17 DE DE10301917A patent/DE10301917B4/de not_active Expired - Fee Related
- 2003-12-23 RU RU2005127035/15A patent/RU2336078C2/ru not_active IP Right Cessation
- 2003-12-23 US US10/542,355 patent/US20070099878A1/en not_active Abandoned
- 2003-12-23 ES ES03815354T patent/ES2351971T3/es not_active Expired - Lifetime
- 2003-12-23 DK DK03815354.0T patent/DK1583525T3/da active
- 2003-12-23 EP EP03815354A patent/EP1583525B1/de not_active Expired - Lifetime
- 2003-12-23 AT AT03815354T patent/ATE479431T1/de active
- 2003-12-23 PT PT03815354T patent/PT1583525E/pt unknown
- 2003-12-23 WO PCT/DE2003/004254 patent/WO2004064827A1/de not_active Ceased
- 2003-12-23 AU AU2003300499A patent/AU2003300499A1/en not_active Abandoned
- 2003-12-23 DE DE50313052T patent/DE50313052D1/de not_active Expired - Lifetime
- 2003-12-23 SI SI200331911T patent/SI1583525T1/sl unknown
- 2003-12-23 JP JP2004566721A patent/JP2006514072A/ja active Pending
-
2010
- 2010-12-01 CY CY20101101103T patent/CY1110957T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20070099878A1 (en) | 2007-05-03 |
| EP1583525A1 (de) | 2005-10-12 |
| ES2351971T3 (es) | 2011-02-14 |
| DE50313052D1 (de) | 2010-10-14 |
| AU2003300499A1 (en) | 2004-08-13 |
| CY1110957T1 (el) | 2015-06-11 |
| RU2005127035A (ru) | 2006-01-27 |
| PT1583525E (pt) | 2010-12-07 |
| SI1583525T1 (sl) | 2011-01-31 |
| DE10301917B4 (de) | 2007-02-01 |
| ATE479431T1 (de) | 2010-09-15 |
| WO2004064827A1 (de) | 2004-08-05 |
| JP2006514072A (ja) | 2006-04-27 |
| DE10301917A1 (de) | 2004-07-29 |
| RU2336078C2 (ru) | 2008-10-20 |
| EP1583525B1 (de) | 2010-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL189019A0 (en) | Pdt (photodynamic therapy) treatment method for cellulites and cosmetic use | |
| CY1115524T1 (el) | Ανθρωπινα μονοκλωνικα αντισωματα εναντι της ανθρωπινης il-4 | |
| DK1814590T3 (da) | Behandling af obesitet og beslægtede sygdomme | |
| DK1853250T3 (da) | Kombinationer og måder til indgivelse af terapeutiske midler og kombinationsterapi | |
| CR8380A (es) | Metodos para preparar y utilizar compuestos novedosos de celulas madre y sus conjuntos | |
| GB2444855B8 (en) | Apparatus and method for photodynamic diagnosis and therapy of skin diseases and light source systemthereof | |
| CY2017013I2 (el) | ΑΝΤΙΣΩΜΑ ΕΝΑΝΤΙΟΝ PDGFR-α ΓΙΑ ΧΡΗΣΗ ΣΤΗΝ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ ΟΓΚΩΝ | |
| CY1107963T1 (el) | Μεσο-υποκαθιστοyμενες πορφυρiνες | |
| DK1742644T3 (da) | Terapeutisk sammensætning indeholdende mindst et pyrrolbenzodiazepin-derivat og fludarabin | |
| DE602004026113D1 (de) | Glp-1-verbindungen | |
| NO20014560L (no) | Quinasoliner og terapautisk anvendelse derav | |
| BR112012010027A2 (pt) | dispositivo para uso pessoal em uma fototerapia | |
| AR007145A1 (es) | Metodo y cateter globo para fototerapia de medios columnares | |
| ATE380548T1 (de) | Verwendung von p53 inhibitoren zur behandlung von nebenerscheinungen bei der krebstherapie | |
| IS7348A (is) | N-pýrasínýl-fenýlsúlfónamíð og notkun þeirra til að meðhöndla flakkboðatengda sjúkdóma | |
| CY1110341T1 (el) | Παραγωγα κιναζολινης και η χρηση τους στην θεραπευτικη αγωγη θρομβοκυτταραιμιας | |
| CY2018006I2 (el) | Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας | |
| CY1115407T1 (el) | Θοριο-227 για χρηση στην ακτινοθεραπεια ασθενειων των μαλακων ιστων | |
| EP1605847A4 (en) | Antibody-targeted photodynamic therapy | |
| IS7444A (is) | Morfólínýl-þvagefna afleiður til notkunar við meðhöndlun á bólguvaldandi sjúkdómum | |
| WO2007100839A3 (en) | Method and apparatus for application of light to tissue | |
| IS6966A (is) | Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma | |
| IS6967A (is) | Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma | |
| CY1110957T1 (el) | Χρηση ουσιων της συνθεσης πορφυρινης σε συνδυασμο με σαλικυλικα και αντιοξειδωτικα για την εφαρμογη στην φωτοθεραπεια για την αγωγη δερματικων ασθενειων και/ή ασθενειων των αρθρωσεων | |
| ATE377429T1 (de) | Anwendung von pdt zur inhibierung von hyperplasie der intima |